PMV Pharmaceuticals Inc banner

PMV Pharmaceuticals Inc
NASDAQ:PMVP

Watchlist Manager
PMV Pharmaceuticals Inc Logo
PMV Pharmaceuticals Inc
NASDAQ:PMVP
Watchlist
Price: 1.47 USD -2% Market Closed
Market Cap: $78.2m

Profitability Summary

PMV Pharmaceuticals Inc's profitability score is 15/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

15/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

15/100
Profitability
Score
15/100
Profitability
Score

Margins

Earnings Waterfall
PMV Pharmaceuticals Inc

Margins Comparison
PMV Pharmaceuticals Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
PMV Pharmaceuticals Inc
NASDAQ:PMVP
78.4m USD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
362.5B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.5B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
170.3B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.3B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.5B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
66.8B AUD
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41.3B USD
Loading...
Loading...

Return on Capital

Return on Capital Comparison
PMV Pharmaceuticals Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
PMV Pharmaceuticals Inc
NASDAQ:PMVP
78.4m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
362.5B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.5B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
170.3B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.3B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.5B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
66.8B AUD
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41.3B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
PMV Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett